ICL (ICL) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ICL Hot Sheet
Join SI Premium – FREE
ICL (NYSE: ICL) reported Q2 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1.44 billion.
For earnings history and earnings-related data on ICL (ICL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 EPS by 12c; Offers Guidance
- UWM Holdings Corporation (UWMC) Reports Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
